nodes	percent_of_prediction	percent_of_DWPC	metapath
Regorafenib—KIT—myenteric nerve plexus—jejunal cancer	0.134	0.134	CbGeAlD
Regorafenib—DDR2—smooth muscle tissue—jejunal cancer	0.0363	0.0363	CbGeAlD
Regorafenib—FRK—lymphoid tissue—jejunal cancer	0.0323	0.0323	CbGeAlD
Regorafenib—DDR2—lymphoid tissue—jejunal cancer	0.029	0.029	CbGeAlD
Regorafenib—FRK—endocrine gland—jejunal cancer	0.0264	0.0264	CbGeAlD
Regorafenib—DDR2—endocrine gland—jejunal cancer	0.0237	0.0237	CbGeAlD
Regorafenib—FGFR2—smooth muscle tissue—jejunal cancer	0.0185	0.0185	CbGeAlD
Regorafenib—TEK—smooth muscle tissue—jejunal cancer	0.0178	0.0178	CbGeAlD
Regorafenib—FLT4—lymphoid tissue—jejunal cancer	0.0177	0.0177	CbGeAlD
Regorafenib—FLT1—smooth muscle tissue—jejunal cancer	0.0172	0.0172	CbGeAlD
Regorafenib—RAF1—smooth muscle tissue—jejunal cancer	0.0171	0.0171	CbGeAlD
Regorafenib—EPHA2—pancreas—jejunal cancer	0.0168	0.0168	CbGeAlD
Regorafenib—TEK—pancreas—jejunal cancer	0.0164	0.0164	CbGeAlD
Regorafenib—DDR2—lymph node—jejunal cancer	0.0164	0.0164	CbGeAlD
Regorafenib—PDGFRA—smooth muscle tissue—jejunal cancer	0.0161	0.0161	CbGeAlD
Regorafenib—FLT1—pancreas—jejunal cancer	0.0159	0.0159	CbGeAlD
Regorafenib—RAF1—pancreas—jejunal cancer	0.0158	0.0158	CbGeAlD
Regorafenib—RET—lymphoid tissue—jejunal cancer	0.0156	0.0156	CbGeAlD
Regorafenib—MAPK11—lymph node—jejunal cancer	0.0155	0.0155	CbGeAlD
Regorafenib—UGT1A9—endocrine gland—jejunal cancer	0.0146	0.0146	CbGeAlD
Regorafenib—EPHA2—lymphoid tissue—jejunal cancer	0.0146	0.0146	CbGeAlD
Regorafenib—KDR—smooth muscle tissue—jejunal cancer	0.0145	0.0145	CbGeAlD
Regorafenib—FLT4—endocrine gland—jejunal cancer	0.0144	0.0144	CbGeAlD
Regorafenib—TEK—lymphoid tissue—jejunal cancer	0.0142	0.0142	CbGeAlD
Regorafenib—FLT1—lymphoid tissue—jejunal cancer	0.0137	0.0137	CbGeAlD
Regorafenib—RAF1—lymphoid tissue—jejunal cancer	0.0136	0.0136	CbGeAlD
Regorafenib—KIT—smooth muscle tissue—jejunal cancer	0.0129	0.0129	CbGeAlD
Regorafenib—PDGFRA—lymphoid tissue—jejunal cancer	0.0129	0.0129	CbGeAlD
Regorafenib—RET—endocrine gland—jejunal cancer	0.0127	0.0127	CbGeAlD
Regorafenib—PDGFRB—smooth muscle tissue—jejunal cancer	0.0126	0.0126	CbGeAlD
Regorafenib—FGFR2—endocrine gland—jejunal cancer	0.0121	0.0121	CbGeAlD
Regorafenib—KIT—pancreas—jejunal cancer	0.0119	0.0119	CbGeAlD
Regorafenib—EPHA2—endocrine gland—jejunal cancer	0.0119	0.0119	CbGeAlD
Regorafenib—PDGFRB—pancreas—jejunal cancer	0.0116	0.0116	CbGeAlD
Regorafenib—KDR—lymphoid tissue—jejunal cancer	0.0116	0.0116	CbGeAlD
Regorafenib—TEK—endocrine gland—jejunal cancer	0.0116	0.0116	CbGeAlD
Regorafenib—BRAF—lymph node—jejunal cancer	0.0116	0.0116	CbGeAlD
Regorafenib—FLT1—endocrine gland—jejunal cancer	0.0112	0.0112	CbGeAlD
Regorafenib—ABL1—smooth muscle tissue—jejunal cancer	0.0112	0.0112	CbGeAlD
Regorafenib—RAF1—endocrine gland—jejunal cancer	0.0111	0.0111	CbGeAlD
Regorafenib—EPHX2—lymph node—jejunal cancer	0.011	0.011	CbGeAlD
Regorafenib—PDGFRA—endocrine gland—jejunal cancer	0.0105	0.0105	CbGeAlD
Regorafenib—ABL1—pancreas—jejunal cancer	0.0104	0.0104	CbGeAlD
Regorafenib—KIT—lymphoid tissue—jejunal cancer	0.0103	0.0103	CbGeAlD
Regorafenib—PDGFRB—lymphoid tissue—jejunal cancer	0.01	0.01	CbGeAlD
Regorafenib—UGT1A1—endocrine gland—jejunal cancer	0.01	0.01	CbGeAlD
Regorafenib—FLT4—lymph node—jejunal cancer	0.00996	0.00996	CbGeAlD
Regorafenib—FGFR1—lymph node—jejunal cancer	0.00983	0.00983	CbGeAlD
Regorafenib—KDR—endocrine gland—jejunal cancer	0.00947	0.00947	CbGeAlD
Regorafenib—ABL1—lymphoid tissue—jejunal cancer	0.00895	0.00895	CbGeAlD
Regorafenib—RET—lymph node—jejunal cancer	0.00879	0.00879	CbGeAlD
Regorafenib—KIT—endocrine gland—jejunal cancer	0.00839	0.00839	CbGeAlD
Regorafenib—EPHA2—lymph node—jejunal cancer	0.00821	0.00821	CbGeAlD
Regorafenib—PDGFRB—endocrine gland—jejunal cancer	0.0082	0.0082	CbGeAlD
Regorafenib—TEK—lymph node—jejunal cancer	0.00801	0.00801	CbGeAlD
Regorafenib—FLT1—lymph node—jejunal cancer	0.00774	0.00774	CbGeAlD
Regorafenib—RAF1—lymph node—jejunal cancer	0.0077	0.0077	CbGeAlD
Regorafenib—ABL1—endocrine gland—jejunal cancer	0.00731	0.00731	CbGeAlD
Regorafenib—PDGFRA—lymph node—jejunal cancer	0.00726	0.00726	CbGeAlD
Regorafenib—KDR—lymph node—jejunal cancer	0.00655	0.00655	CbGeAlD
Regorafenib—KIT—lymph node—jejunal cancer	0.0058	0.0058	CbGeAlD
Regorafenib—PDGFRB—lymph node—jejunal cancer	0.00567	0.00567	CbGeAlD
Regorafenib—CYP2C19—endocrine gland—jejunal cancer	0.00543	0.00543	CbGeAlD
Regorafenib—CYP2B6—lymphoid tissue—jejunal cancer	0.00521	0.00521	CbGeAlD
Regorafenib—ABL1—lymph node—jejunal cancer	0.00505	0.00505	CbGeAlD
Regorafenib—CYP2C8—endocrine gland—jejunal cancer	0.00474	0.00474	CbGeAlD
Regorafenib—CYP2B6—endocrine gland—jejunal cancer	0.00425	0.00425	CbGeAlD
Regorafenib—CYP2C9—endocrine gland—jejunal cancer	0.00421	0.00421	CbGeAlD
Regorafenib—ABCB1—pancreas—jejunal cancer	0.00322	0.00322	CbGeAlD
Regorafenib—CYP3A4—endocrine gland—jejunal cancer	0.00321	0.00321	CbGeAlD
Regorafenib—ABCG2—lymph node—jejunal cancer	0.00318	0.00318	CbGeAlD
Regorafenib—ABCB1—lymphoid tissue—jejunal cancer	0.00278	0.00278	CbGeAlD
Regorafenib—ABCB1—endocrine gland—jejunal cancer	0.00227	0.00227	CbGeAlD
Regorafenib—ABCB1—lymph node—jejunal cancer	0.00157	0.00157	CbGeAlD
